INMB logo

INmune Bio (INMB)

Profile

Full Name

INmune Bio, Inc.

Ticker Symbol

INMB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 4, 2019

Indexes

Not included

Website

http://www.inmunebio.com

Employees

13

Key Details

Price

$7.31(-2.14%)

Market cap

$167.62M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$14.00K(-90.97% YoY)

Annual EPS

-$2.11(-26.35% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.31
INMB price is $7.31

30-Day Relative Volume

0.86
INMB 30-day relative volume is 0.86

Price Performance

Price Most recent change

-2.14%
INMB price was down -2.14% on Apr 16, 2025

Price YTD change

+56.53%
INMB price is up +56.53% since January 1st

Price 1-year change

-13.29%
INMB price is down -13.29% year-on-year

Price 3-year change

-12.03%
INMB price is down -12.03% over the past 3 years

Price Range

Price All-time high

$30.37
INMB price is currently -75.93% below its historical high of $30.37

Price 3-year low

$4.32
INMB price is currently +69.21% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$167.62M
INMB market capitalization is $167.62 million

Market cap 3-year change

+12.4%
INMB market capitalization is up +12.4% over the past 3 years

Market cap All-time high

$496.89M
INMB market capitalization is currently -66.27% below its historical high of $496.89 million

Market cap sector rank

55.26%
INMB market capitalization is higher than 55.26% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+25.97%
INMB shares outstanding is up +25.97% year-on-year

Shares Outstanding 3-Year Change

+27.77%
INMB shares outstanding is up +27.77% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.58
INMB beta is 1.58

200-day SMA

$6.77
INMB price is currently +7.97% above its 200-day simple moving average

50-day SMA

$8.15
INMB price is currently -10.30% below its 50-day simple moving average

RSI

46.62
INMB 14-day relative strength index is 46.62

Volume

0.86
INMB 30-day relative volume is 0.86

ATR

$0.72
INMB average true range is $0.72

10-day Historical Volatility

114.40%
INMB 10-day historical volatility is 114.40%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$14.00K
INMB annual revenue is $14.00 thousand

Revenue Analysts estimate

$9.08M
INMB annual revenue is currently -99.85% lower than the consensus analysts' forecast

Revenue 1-year change

-90.97%
INMB annual revenue is down -90.97% year-on-year

Revenue Sector rank

2.46%
INMB annual revenue is higher than 2.46% of companies in Healthcare sector

EPS

EPS

-$2.11
INMB annual earnings per share is -$2.11

EPS Analysts estimate

-$1.79
INMB annual earnings per share is currently +17.55% higher than the consensus analysts' forecast

EPS 1-year change

-26.35%
INMB annual earnings per share is down -26.35% year-on-year

EPS Sector rank

37.77%
INMB annual earnings per share is higher than 37.77% of companies in Healthcare sector

Profit

Gross profit

-
INMB annual gross profit value is unknown

Gross margin

-
INMB annual gross profit margin value is unknown

Operating profit

-$42.63M
INMB annual operating income is -$42.63 million

Operating margin

-304.54K%
INMB annual operating profit margin is -304.54 thousand%

Net income

-$42.08M
INMB annual net profit is -$42.08 million

Net margin

-300.59K%
INMB annual net profit margin is -300.59 thousand%

Expenses

Total expenses

$42.65M
INMB annual total expenses is $42.65 million

Operating expenses

$42.65M
INMB annual total operating expenses is $42.65 million

Cost of goods sold

-
INMB annual cost of goods sold value is unknown

Selling, general & administrative expenses

$9.48M
INMB annual SGA is $9.48 million

Depreciation and amortization

-
INMB annual depreciation & amortization value is unknown

Interest expense

-
INMB annual interest expense value is unknown

Income tax

-
INMB annual income tax value is unknown

EBIT & EBITDA

EBIT

-$42.63M
INMB annual earnings before interest & taxes is -$42.63 million

EBITDA

-$42.63M
INMB annual EBITDA is -$42.63 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$39.56M
INMB annual total assets is $39.56 million

Non current assets

$16.90M
INMB annual long term assets is $16.90 million

Current assets

$22.66M
INMB annual total current assets is $22.66 million

Cash and cash equivalents

$20.92M
INMB annual cash & cash equivalents is $20.92 million

Accounts receivable

-
INMB annual accounts receivable value is unknown

Inventory

-
INMB annual inventory value is unknown

Liabilities

Total liabilities

$7.46M
INMB annual total liabilities is $7.46 million

Long term liabilities

$244.00K
INMB annual total long term liabilities is $244.00 thousand

Current liabilities

$7.22M
INMB annual total current liabilities is $7.22 million

Accounts payable

$6.56M
INMB annual accounts payable is $6.56 million

Debt

Total debt

$384.00K
INMB annual total debt is $384.00 thousand

Total debt 1-year change

-96.32%
INMB annual total debt is down -96.32% year-on-year

Long term debt

$244.00K
INMB annual long term debt is $244.00 thousand

Short term debt

$140.00K
INMB annual short term debt is $140.00 thousand

Equity & Capital

Shareholders equity

$32.10M
INMB annual stockholders equity is $32.10 million

Book value

$32.10M
INMB annual book value is $32.10 million

Retained earnings

-$163.10M
INMB annual retained earnings is -$163.10 million

Working capital

$15.44M
INMB annual working capital is $15.44 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$33.36M
INMB annual cash flow from operations is -$33.36 million

Cash from operations 1-year change

-178.47%
INMB annual cash flow from operations is down -178.47% year-on-year

Cash from investing

-
INMB annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
INMB annual cash flow from investing activities 1-year change is unknown

Cash from financing

$18.21M
INMB annual cash flow from financing activities is $18.21 million

Cash from financing 1-year change

+531.03%
INMB annual cash flow from financing activities is up +531.03% year-on-year

CAPEX

CAPEX

-
INMB annual capital expenditures value is unknown

CAPEX 1-year change

-
INMB annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$33.36M
INMB annual free cash flow is -$33.36 million

Free cash flow 1-year change

-178.47%
INMB annual free cash flow is down -178.47% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
INMB annual gross profit margin value is unknown

Operating margin

-304.54K%
INMB annual operating profit margin is -304.54 thousand%

Net margin

-300.59K%
INMB annual net profit margin is -300.59 thousand%

ROA & ROE

ROA

-87.16%
INMB annual return on assets is -87.16%

ROE

-119.83%
INMB annual return on equity is -119.83%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
INMB price to earnings ratio value is unknown

PE ratio Sector rank

-
INMB price to earnings ratio is unknown

PB Ratio

PB ratio

5.22
INMB price to book ratio is 5.22

PB ratio Sector rank

84.02%
INMB price to book ratio is higher than 84.02% of companies in Healthcare sector

PS Ratio

PS ratio

-
INMB price to sales ratio value is unknown

PS ratio Sector rank

-
INMB price to sales ratio is unknown

Enterprise value

Enterprise value

$147.08M
INMB enterprise value is $147.08 million

Enterprise value Sector rank

54.34%
INMB enterprise value is higher than 54.34% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.45
INMB EV/EBITDA is -3.45

EV/EBITDA Sector rank

23.74%
INMB EV/EBITDA is higher than 23.74% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.14
INMB annual current ratio is 3.14

Quick ratio

-
INMB annual quick ratio value is unknown

Leverage

Debt to equity

0.00
INMB annual debt to equity ratio is 0.00

Interest coverage ratio

-
INMB annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
INMB piotroski f-score value is unknown

Altman Z-Score

4.61
INMB altman z-score is 4.61

Analyst ratings

Recent major analysts updates

Feb 13, 25 Maxim Group
Buy
Feb 11, 25 Scotiabank
Sector Outperform
Jun 1, 23 Baird
Outperform
May 24, 22 BTIG
Buy
May 24, 22 B. Riley Securities
Neutral
Jan 24, 22 B. Riley Securities
Buy
Apr 21, 21 B. Riley Securities
Buy
Apr 21, 21 B. Riley FBR
Buy
Nov 25, 20 Roth Capital
Buy
Nov 25, 20 Maxim Group
Buy

Institutional Ownership

Similar stocks

INBX logo
Inhibrx Biosciences (INBX)
FULC logo
Fulcrum Therapeutics (FULC)
TOI logo
Oncology Institute (TOI)
Aardvark Therapeutics (AARD)
American Oncology Network (AONC)
PROC logo
Procaps Group SA (PROC)
UTMD logo
Utah Medical Products (UTMD)
IPHA logo
Innate Pharma SA (IPHA)
VYGR logo
Voyager Therapeutics (VYGR)
  • What is the ticker symbol for INmune Bio?
  • Does INmune Bio pay dividends?
  • What sector is INmune Bio in?
  • What industry is INmune Bio in?
  • What country is INmune Bio based in?
  • When did INmune Bio go public?
  • Is INmune Bio in the S&P 500?
  • Is INmune Bio in the NASDAQ 100?
  • Is INmune Bio in the Dow Jones?
  • When was INmune Bio's last earnings report?
  • When does INmune Bio report earnings?
  • Should I buy INmune Bio stock now?

What is the ticker symbol for INmune Bio?

The ticker symbol for INmune Bio is NASDAQ:INMB

Does INmune Bio pay dividends?

No, INmune Bio does not pay dividends

What sector is INmune Bio in?

INmune Bio is in the Healthcare sector

What industry is INmune Bio in?

INmune Bio is in the Biotechnology industry

What country is INmune Bio based in?

INmune Bio is headquartered in United States

When did INmune Bio go public?

INmune Bio's initial public offering (IPO) was on February 4, 2019

Is INmune Bio in the S&P 500?

No, INmune Bio is not included in the S&P 500 index

Is INmune Bio in the NASDAQ 100?

No, INmune Bio is not included in the NASDAQ 100 index

Is INmune Bio in the Dow Jones?

No, INmune Bio is not included in the Dow Jones index

When was INmune Bio's last earnings report?

INmune Bio's most recent earnings report was on Mar 27, 2025

When does INmune Bio report earnings?

The next expected earnings date for INmune Bio is May 9, 2025

Should I buy INmune Bio stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page